167 related articles for article (PubMed ID: 20813731)
41. [Ventricular tachyarrhythmia in acute and chronic myocardial ischemia: value of diagnostic procedures].
Steinbeck G
Z Kardiol; 1993; 82 Suppl 5():149-54. PubMed ID: 8154156
[TBL] [Abstract][Full Text] [Related]
42. Characterization of reversible myocardial dysfunction by magnetic resonance imaging.
Fedele F; Scopinaro F; Montesano T; Di Cesare E; Di Renzi P; Vitarelli A; Dagianti A
Herz; 1994 Aug; 19(4):210-20. PubMed ID: 7959535
[TBL] [Abstract][Full Text] [Related]
43. Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study.
Flynn M; Curtin R; Nowicki ER; Rajeswaran J; Flamm SD; Blackstone EH; Mihaljevic T
J Thorac Cardiovasc Surg; 2009 May; 137(5):1063-70.e2. PubMed ID: 19379967
[TBL] [Abstract][Full Text] [Related]
44. Clinical applications of cardiac magnetic resonance imaging.
Pilz G; Heer T; Harrer E; Ali E; Hoefling B
Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
[TBL] [Abstract][Full Text] [Related]
45. MRI in the assessment of ischaemic heart disease.
Dastidar AG; Rodrigues JC; Baritussio A; Bucciarelli-Ducci C
Heart; 2016 Feb; 102(3):239-52. PubMed ID: 26719357
[No Abstract] [Full Text] [Related]
46. [Myocardial viability in man: state of the art and directions to pursue].
Vanoverschelde JL
Bull Mem Acad R Med Belg; 1999; 154(1):91-6; discussion 96-8. PubMed ID: 10535159
[TBL] [Abstract][Full Text] [Related]
47. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
[TBL] [Abstract][Full Text] [Related]
48. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
[TBL] [Abstract][Full Text] [Related]
49. [Anomalies of myocardial contractility: CT and MR appearance].
Laissy JP; Vignaux O; Dacher JN
J Radiol; 2004 Feb; 85(2 Pt 1):95-9. PubMed ID: 15094622
[TBL] [Abstract][Full Text] [Related]
50. [MRI of ischemic heart disease].
Nishimura T; Ito H; Kubota T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():273-9. PubMed ID: 12734984
[No Abstract] [Full Text] [Related]
51. Role of CMR in Prognostic Stratification in Myocardial Infarction.
Das A; Plein S; Dall'Armellina E
Rev Esp Cardiol (Engl Ed); 2019 Feb; 72(2):115-119. PubMed ID: 30224251
[No Abstract] [Full Text] [Related]
52. Imaging techniques in the evaluation of post-infarction function and scar.
Pozo E; Sanz J
Rev Esp Cardiol (Engl Ed); 2014 Sep; 67(9):754-64. PubMed ID: 25172072
[TBL] [Abstract][Full Text] [Related]
53. Noncompaction of the myocardium the value of cardiovascular magnetic resonance imaging.
Schuster A; Duckett SG; Hedström E; Chiribiri A; Techen G; Nagel E
J Am Coll Cardiol; 2011 Sep; 58(13):e25. PubMed ID: 21920258
[No Abstract] [Full Text] [Related]
54. Value and limitations of electromechanical endocardial mapping in the assessment of global and regional left ventricular function and transmural extent of infarction: a comparison with cardiovascular magnetic resonance.
van der Vleuten PA; Nijveldt R; Tan ES; Tio RA; van Rossum AC; Zijlstra F
EuroIntervention; 2010 Nov; 6(5):616-22. PubMed ID: 21044916
[TBL] [Abstract][Full Text] [Related]
55. Advances in cardiovascular magnetic resonance in ischaemic heart disease and non-ischaemic cardiomyopathies.
Motwani M; Kidambi A; Greenwood JP; Plein S
Heart; 2014 Nov; 100(21):1722-33. PubMed ID: 24694798
[No Abstract] [Full Text] [Related]
56. Differentiation of acute myocardial infarction from chronic myocardial scar with MRI.
Choi BW
Korean J Radiol; 2006; 7(1):1-3. PubMed ID: 16549948
[No Abstract] [Full Text] [Related]
57. Mystery of myocardial midwall late enhancement?
Alter P
Int J Cardiovasc Imaging; 2014 Dec; 30(8):1569-70. PubMed ID: 25117644
[No Abstract] [Full Text] [Related]
58. Cardiac allograft vasculopathy : complications and imaging studies.
Di Bella G; Minutoli F; Coglitore S; Recupero A; Donato R; Caruso R; Grimaldi P; Lentini S
Herz; 2011 Oct; 36(7):630-6. PubMed ID: 20981397
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular MRI for detection of myocardial viability and ischaemia.
Mahrholdt H; Klem I; Sechtem U
Heart; 2007 Jan; 93(1):122-9. PubMed ID: 17170353
[No Abstract] [Full Text] [Related]
60. Intra-scar perfusion heterogeneity by cardiac magnetic resonance in a porcine model of non-reperfused myocardial infarction.
Guzmán-Martínez G; Fernández-Friera L; Moral S; Shapiro S; Bates D; Hajjar R; García MJ; Fuster V; Sanz J
Int J Cardiol; 2014 Oct; 176(3):1288-9. PubMed ID: 25129306
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
